These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35903569)
1. Effect of Thyroxine and Thyrotropin on Bone Mineral Density in Postmenopausal Women: A Systematic Review. Poudel P; Chalasani R; Goonathilake MR; Waqar S; George S; Jean-Baptiste W; Yusuf Ali A; Inyang B; Koshy FS; George K; Mohammed L Cureus; 2022 Jun; 14(6):e26353. PubMed ID: 35903569 [TBL] [Abstract][Full Text] [Related]
2. Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis. Kwak D; Ha J; Won Y; Kwon Y; Park S BMJ Open; 2021 May; 11(5):e043007. PubMed ID: 33986046 [TBL] [Abstract][Full Text] [Related]
3. Influence of thyroid hormones on bone density. Begić A; Begić A; Arnautović-Halimić A Med Glas (Zenica); 2020 Feb; 17(1):35-40. PubMed ID: 31663319 [TBL] [Abstract][Full Text] [Related]
4. The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women. Baqi L; Payer J; Killinger Z; Susienkova K; Jackuliak P; Cierny D; Langer P Endocr Regul; 2010 Jan; 44(1):9-15. PubMed ID: 20151763 [TBL] [Abstract][Full Text] [Related]
5. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre. De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627 [TBL] [Abstract][Full Text] [Related]
6. Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis. Hawkins F; Rigopoulou D; Papapietro K; Lopez MB Calcif Tissue Int; 1994 Jan; 54(1):16-9. PubMed ID: 8118747 [TBL] [Abstract][Full Text] [Related]
7. High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women. Hwangbo Y; Kim JH; Kim SW; Park YJ; Park DJ; Kim SY; Shin CS; Cho NH Osteoporos Int; 2016 Feb; 27(2):457-62. PubMed ID: 26252978 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of vitamin D in relation to bone health. Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161 [TBL] [Abstract][Full Text] [Related]
9. Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism. Affinito P; Sorrentino C; Farace MJ; di Carlo C; Moccia G; Canciello P; Palomba S; Nappi C Acta Obstet Gynecol Scand; 1996 Oct; 75(9):843-8. PubMed ID: 8931510 [TBL] [Abstract][Full Text] [Related]
10. Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy. Greenspan SL; Greenspan FS; Resnick NM; Block JE; Friedlander AL; Genant HK Am J Med; 1991 Jul; 91(1):5-14. PubMed ID: 1858829 [TBL] [Abstract][Full Text] [Related]
11. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women. Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Guo CY; Weetman AP; Eastell R Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039 [TBL] [Abstract][Full Text] [Related]
13. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study. Appetecchia M Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872 [TBL] [Abstract][Full Text] [Related]
14. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. Reverter JL; Holgado S; Alonso N; Salinas I; Granada ML; Sanmartí A Endocr Relat Cancer; 2005 Dec; 12(4):973-81. PubMed ID: 16322336 [TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in postmenopausal women treated with L-thyroxine. Adlin EV; Maurer AH; Marks AD; Channick BJ Am J Med; 1991 Mar; 90(3):360-6. PubMed ID: 2003518 [TBL] [Abstract][Full Text] [Related]
16. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491 [TBL] [Abstract][Full Text] [Related]
17. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma. Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742 [TBL] [Abstract][Full Text] [Related]
18. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Han W; Bai X; Wang N; Han L; Sun X; Chen X Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105 [TBL] [Abstract][Full Text] [Related]
19. The effect of levothyroxine therapy on bone mineral density: a systematic review of the literature. Schneider R; Reiners C Exp Clin Endocrinol Diabetes; 2003 Dec; 111(8):455-70. PubMed ID: 14714266 [TBL] [Abstract][Full Text] [Related]
20. Long-term thyroxine treatment and bone mineral density. Franklyn JA; Betteridge J; Daykin J; Holder R; Oates GD; Parle JV; Lilley J; Heath DA; Sheppard MC Lancet; 1992 Jul; 340(8810):9-13. PubMed ID: 1351654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]